Edelris Symposium on AS-MS in Drug Discovery

Virscidian is proud to sponsor the 6th Edelris Annual Symposium on Affinity Selection Mass Spectrometry (AS-MS) in Drug Discovery, hosted by AstraZeneca on September 3, 2026, at The Discovery Centre in Cambridge, UK. The symposium brings together scientists from industry and academia to share emerging technologies, practical applications, and new approaches advancing AS-MS screening and small-molecule drug discovery.

Be sure to join in at 8:45 am ET to see Don Nguyen's presentation on Automating Affinity Selection Mass Spectrometry for Confident Hit Identification.

‍